Carmeliet, Peter

A mouse model for Zellweger syndrome

Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P. E., Collen, D., et al. (1997) · Nature Genetics

Metabolism and Genetic DisordersHereditary Neurological Disorders

Cited by 275

The neurovascular link in health and disease: molecular mechanisms and therapeutic implications

Quaegebeur, A., Lange, C., & Carmeliet, P. (2011) · Neuron

Barrier Structure and Function StudiesNeurological Disease Mechanisms and Treatments

Cited by 247

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P., & Eltzschig, H. K. (2024) · Nature Reviews Drug Discovery

Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment

Cited by 245

A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects

Dor, Y., Camenisch, T. D., Itin, A., Fishman, G. I., McDonald, J. A., Carmeliet, P., & Keshet, E. (2001) · Development

Congenital heart defects researchDevelopmental Biology and Gene Regulation

Cited by 240

Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice

Kojima, H., Gu, H., Nomura, S., Caldwell, C. C., Kobata, T., Carmeliet, P., Semenza, G. L., & Sitkovsky, M. V. (2002) · Proceedings of the National Academy of Sciences

T-cell and B-cell ImmunologySystemic Lupus Erythematosus Research

Cited by 224

Role of glutamine synthetase in angiogenesis beyond glutamine synthesis

Eelen, G., Dubois, C., Cantelmo, A. R., Goveia, J., Brüning, U., DeRan, M., Jarugumilli, G., van Rijssel, J., Saladino, G., Comitani, F., et al. (2018) · Nature

Angiogenesis and VEGF in CancerProtein Kinase Regulation and GTPase Signaling

Cited by 220

The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation

Wolter, P., Stefan, C., Decallonne, B., Dumez, H., Bex, M., Carmeliet, P., & Schöffski, P. (2008) · British Journal of Cancer

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Cited by 198

Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice

Walmsley, S. R., Chilvers, E. R., Thompson, A. A., Vaughan, K., Marriott, H. M., Parker, L. C., Shaw, G., Parmar, S., Schneider, M., Sabroe, I., et al. (2011) · Journal of Clinical Investigation

Cell death mechanisms and regulationNeutrophil, Myeloperoxidase and Oxidative Mechanisms

Cited by 191

VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

Carmeliet, P., & de Almodovar, C. R. (2013) · Cellular and Molecular Life Sciences

Angiogenesis and VEGF in CancerAxon Guidance and Neuronal Signaling

Cited by 173

Functional reprogramming of regulatory T cells in the absence of Foxp3

Charbonnier, L.-M., Cui, Y., Stephen-Victor, E., Harb, H., Lopez, D., Bleesing, J. J., Garcia-Lloret, M. I., Chen, K., Ozen, A., Carmeliet, P., et al. (2019) · Nature Immunology

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 145

Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination

Binder, M. D., Cate, H. S., Prieto, A. L., Kemper, D., Butzkueven, H., Gresle, M. M., Cipriani, T., Jokubaitis, V. G., Carmeliet, P., & Kilpatrick, T. J. (2008) · The Journal of Neuroscience

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 138

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin

Stegen, S., Stockmans, I., Moermans, K., Thienpont, B., Maxwell, P. H., Carmeliet, P., & Carmeliet, G. (2018) · Nature Communications

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 126

An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates

Goveia, J., Rohlenova, K., Taverna, F., Treps, L., Conradi, L.-C., Pircher, A., Geldhof, V., de Rooij, L. P. M. H., Kalucka, J., Sokol, L., et al. (2020) · Cancer Cell

Angiogenesis and VEGF in CancerSingle-cell and spatial transcriptomics

Cited by 125

Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development

Vinores, S. A., Xiao, W., Aslam, S., Shen, J., Oshima, Y., Nambu, H., Liu, H., Carmeliet, P., & Campochiaro, P. A. (2006) · Journal of Cellular Physiology

Retinal Diseases and TreatmentsAngiogenesis and VEGF in Cancer

Cited by 99

Endothelial cell metabolism in cardiovascular physiology and disease

Pasut, A., Lama, E., Van Craenenbroeck, A. H., Kroon, J., & Carmeliet, P. (2025) · Nature Reviews Cardiology

Nitric Oxide and Endothelin EffectsAngiogenesis and VEGF in Cancer

Cited by 74

VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway

Lee, C., Chen, R., Sun, G., Liu, X., Lin, X., He, C., Xing, L., Liu, L., Jensen, L. D., Kumar, A., et al. (2023) · Signal Transduction and Targeted Therapy

Angiogenesis and VEGF in CancerFibroblast Growth Factor Research

Cited by 72

Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues

Janssen, A., Gressens, P., Grabenbauer, M., Baumgart, E., Schad, A., Vanhorebeek, I., Brouwers, A., Declercq, P. E., Fahimi, D., Evrard, P., et al. (2003) · The Journal of Neuroscience

Metabolism and Genetic DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 65

Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective

Missiaen, R., Morales-Rodriguez, F., Eelen, G., & Carmeliet, P. (2017) · Vascular Pharmacology

Angiogenesis and VEGF in CancerCancer, Hypoxia, and Metabolism

Cited by 58

Peroxisomal multifunctional protein-2 deficiency causes neuroinflammation and degeneration of Purkinje cells independent of very long chain fatty acid accumulation

Verheijden, S., Bottelbergs, A., Krysko, O., Krysko, D. V., Beckers, L., De Munter, S., Van Veldhoven, P. P., Wyns, S., Kulik, W., Nave, K.-A., et al. (2013) · Neurobiology of Disease

Metabolism and Genetic DisordersGenetic Neurodegenerative Diseases

Cited by 54

PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development

Sents, W., Meeusen, B., Kalev, P., Radaelli, E., Sagaert, X., Miermans, E., Haesen, D., Lambrecht, C., Dewerchin, M., Carmeliet, P., et al. (2017) · Cancer Research

Protein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling

Cited by 42